VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_21-vv-00589
Package ID: USCOURTS-cofc-1_21-vv-00589
Petitioner: Firas Ido
Filed: 2021-01-12
Decided: 2025-09-02
Vaccine: Tdap
Vaccination date: 2019-06-24
Condition: brachial neuritis/plexopathy
Outcome: compensated
Award amount USD: 10000

AI-assisted case summary:
Firas Ido filed a petition on January 12, 2021, seeking compensation under the National Vaccine Injury Compensation Program. He alleged that he suffered from brachial neuritis/plexopathy as a result of a Tdap vaccination received on June 24, 2019, and an influenza vaccine received on November 30, 2022. The respondent denied that the vaccines caused the petitioner's condition or its residual effects. Despite maintaining their positions, both parties entered into a joint stipulation on August 5, 2025, agreeing that the case could be settled and that compensation should be awarded. The court reviewed the stipulation and found it to be reasonable, adopting it as its decision. The stipulation awarded Firas Ido a lump sum of $10,000.00, to be paid through an ACH deposit to his counsel's IOLTA account for prompt disbursement. This award is intended to compensate for all damages available under the program. The decision directs that judgment be entered unless a motion for review is filed.

Theory of causation field:
unclear

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_21-vv-00589-0
Date issued/filed: 2025-09-02
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 8/5/2025) regarding 75 DECISION of Special Master - Stipulation. Signed by Special Master Jennifer A. Shah. (sl) Service on parties made.
--------------------------------------------------------------------------------
Case 1:21-vv-00589-UNJ Document 79 Filed 09/02/25 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 21-589V
* * * * * * * * * * * * * * * * * * * * * * * * * *
*
*
FIRAS IDO,
*
*
Petitioner, * UNPUBLISHED
*
*
v.
*
* Filed: August 5, 2025
SECRETARY OF HEALTH AND *
HUMAN SERVICES, *
*
*
Respondent. *
*
* * * * * * * * * * * * * * * * * * * * * * * * * *
Christopher J. Webb, Black McLaren Jones Ryland & Griffee, Memphis, TN, for Petitioner.
Crystal Fialkowski, U.S. Department of Justice, Washington, DC, for Respondent.
DECISION ON JOINT STIPULATION1
On January 12, 2021, Firas Ido (“Petitioner”) filed a petition, seeking compensation under
the National Vaccine Injury Compensation Program (“the Vaccine Program”).2 Pet., ECF No. 1.
Petitioner alleges he suffered from brachial neuritis/plexopathy as a result of a tetanus, diphtheria,
and acellular pertussis (“Tdap”) vaccination he received on June 24, 2019, and an influenza (“flu”)
vaccine on November 30, 2022. See Stipulation ¶ 2, 4, dated August 5, 2025 (ECF No. 74).
Respondent denies “that petitioner’s alleged brachial neuritis/plexopathy or its residual
effects were caused-in-fact or significantly aggravated by the vaccines; and denies that the
1 Although this Decision has been formally designated “not to be published,” it will nevertheless be posted
on the Court of Federal Claims’ website in accordance with the E-Government Act of 2002, 44 U.S.C. §
3501 (2012). This means the Decision will be available to anyone with access to the internet. As
provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the Decision’s inclusion of
certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen
days within which to request redaction “of any information furnished by that party: (1) that is a trade secret
or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files
or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.”
Vaccine Rule 18(b). Otherwise, the Decision in its present form will be available. Id.
2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L.
No. 99-660, 100 Stat. 3755 (codified as amended at 42 U.S.C. §§ 300aa-10–34 (2012)) (hereinafter
“Vaccine Act” or “the Act”). All subsequent references to sections of the Vaccine Act shall be to the
pertinent subparagraph of 42 U.S.C. § 300aa.

Case 1:21-vv-00589-UNJ Document 79 Filed 09/02/25 Page 2 of 7
vaccines caused petitioner any other injury or petitioner’s current condition.” See Stipulation ¶ 6.
Nonetheless, both parties, while maintaining their above-stated positions, agreed in a stipulation
filed August 5, 2025, that the issues before them can be settled and that a decision should be entered
awarding Petitioner compensation.
I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation
is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth
therein.
The stipulation awards:
a lump sum of $10,000.00 to be paid through an ACH deposit to Petitioner’s counsel’s
IOLTA account for prompt disbursement to Petitioner.
Stipulation ¶ 8. This award represents compensation for all damages that would be available under
42 U.S.C. § 300aa-15(a).
I approve a Vaccine Program award in the requested amount set forth above to be made to
Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk
of the Court is directed to enter judgment herewith.3
IT IS SO ORDERED.
s/ Jennifer A. Shah
Jennifer A. Shah
Special Master
3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly filing notice
renouncing their right to seek review.

Case 1:21-vv-00589-UNJ Document 79 Filed 09/02/25 Page 3 of 7

Case 1:21-vv-00589-UNJ Document 79 Filed 09/02/25 Page 4 of 7

Case 1:21-vv-00589-UNJ Document 79 Filed 09/02/25 Page 5 of 7

Case 1:21-vv-00589-UNJ Document 79 Filed 09/02/25 Page 6 of 7

Case 1:21-vv-00589-UNJ Document 79 Filed 09/02/25 Page 7 of 7